Key Takeaways for CVS Health Stock as of July 2026

• CVS Health delivered $2.57 in adjusted EPS for Q1 2026 and raised full-year guidance to $7.30-$7.50, confirming the earnings turnaround has traction.
• The quarterly dividend held at $0.67 per share, unchanged for eight straight quarters.
• A 29% payout ratio paired with a 2.47% NTM yield captures the tension: dividend coverage has never been stronger in the visible data, but the stock’s rally compressed the yield to its trailing-year low.
• TIKR’s mid-case model targets $130 for CVS Health stock by December 2030, implying 23% total return at a 5% annualized rate.

CVS Health stock’s yield dropped from nearly 5% to 2.47% in under a year. See the full dividend history on…